bupropion

(redirected from Wellbutrin sr)
Also found in: Medical.

bu·pro·pi·on

 (byo͞o-prō′pē-ŏn′)
n.
A drug, C13H18ClNO, used in its hydrochloride form for the treatment of depression and as an aid in smoking cessation. It is a weak inhibitor of norepinephrine and dopamine reuptake in the central nervous system.

[bu(tyl) + propi(ophen)on(e), a ketone (propio(nic acid) + phen(yl) + -one).]

bupropion

(bjuːˈprəʊpɪɒn)
n
an antidepressant drug used to help people stop smoking
Translations

bupropion

n bupropión m
Mentioned in ?
References in periodicals archive ?
India-based Dr Reddy's Laboratories has introduced Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic equivalent generic version of Wellbutrin SR (bupropion HCl) Sustained-Release Tablets, in the United States, it was reported yesterday.
Bupropion is the genetic name for the brand Wellbutrin SR, marketed in the United States by GlaxoSmithKline PLC.
Bupropion, the generic name for the brand Wellbutrin SR is marketed in the US by Glaxo Smithkline.
In contrast, the medications mirtazapine (Remeron, Remeron SolTab) and bupropion (Wellbutrin, Wellbutrin SR, and Wellbutrin XL) have been associated with a lower incidence of sexual side effects.
The indictment doesn't name the company, but GlaxoSmithKline has confirmed Stevens is now retired from its law department and the drug in question was Wellbutrin SR.
Bupropion HCl SR tablets, the generic equivalent of GlaxoSmithKline's Wellbutrin SR, are now available from Actavis in the following strengths: 100mg, 150mg, and 200mg.
unit had received approval to market a generic version of GlaxoSmithKline Plc's Wellbutrin SR extended release tablets.
Wellbutrin XL once daily maintains bupropion plasma concentrations over 24 hours, helping to eliminate the evening peak in bupropion levels seen with Wellbutrin SR twice daily.
Glaxo, which employs 2,200 people at factories in County Durham and Cumbria, said generic versions of Wellbutrin SR and Paxil IR had cost it over pounds 1.
Drugs with significant potential that are having generic equivalents hit the market are: Ortho-Novum 7/7/7 * (birth control) Ortho Tri-Clyclen * (birth control) Accupril (blood pressure) Nolvadex (breast cancer) Topamax (anti-convulsant) Glucophage XR (diabetes) Monopril (blood pressure) Remeron (antidepressant) Alphagan (glaucoma) Serzone (antidepressant) Glucovance (diabetes) Glucotrol XL (diabetes) Wellbutrin SR (antidepressant) Zyban (smoking cessation) Neurontin (anti-convulsant) Tiazac (blood pressure) Prozac (antidepressant) Prilosec (gastritis)
Those agents include fluvoxamine (Luvox), bupropion (Wellbutrin, Wellbutrin SR, Zyban), venlafaxine (Effexor, Effexor XR), and nefazodone (Serzone).
Bupropion - sold as Zyban and Wellbutrin SR - has emerged as a front- line treatment since receiving approval as a smoking cessation aid by the Food and Drug Administration in 1997.